Lawrence B. Cohen’s AbbVie ABBV Stock Holding History

Lawrence B. Cohen’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,370	Closed	-$204K	–	7
2023 Q3	$204K	Buy	+1,370	New	+$201K	0.14%	57
2023 Q1	–	Sell	-2,199	Closed	-$355K	–	64
2022 Q4	$355K	Buy	+2,199	New	+$337K	0.19%	80
2022 Q1	–	Sell	-2,515	Closed	-$341K	–	65
2021 Q4	$341K	Buy	+2,515	New	+$297K	0.13%	76
2021 Q3	–	Sell	-6,006	Closed	-$677K	–	76
2021 Q2	$677K	Hold	6,006	–	–	0.35%	52
2021 Q1	$650K	Sell	6,006 -15	-0.2%	-$1.6K	0.35%	53
2020 Q4	$645K	Buy	6,021 +89	+2%	+$8.55K	0.36%	52
2020 Q3	$520K	Hold	5,932	–	–	0.32%	54
2020 Q2	$582K	Hold	5,932	–	–	0.39%	51
2020 Q1	$452K	Buy	5,932 +1,200	+25%	+$102K	0.35%	53
2019 Q4	$419K	Hold	4,732	–	–	0.25%	62
2019 Q3	$358K	Sell	4,732 -117	-2%	-$8.02K	0.23%	65
2019 Q2	$353K	Buy	+4,849	New	+$381K	0.24%	61

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lawrence B. Cohen's ABBV Position: Q4 2023 in Review

Lawrence B. Cohen sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,370 shares — an estimated $204K sold.

Lawrence B. Cohen first reported a position in ABBV in Q2 2019 and held it in 12 quarters. The position peaked at $677K in Q2 2021. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Lawrence B. Cohen reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
Lawrence B. Cohen sold 1,370 AbbVie shares in Q4 2023, an estimated $204K.
Lawrence B. Cohen first reported a position in AbbVie in Q2 2019 and held it in 12 quarters.
Lawrence B. Cohen's AbbVie position peaked at $677K in Q2 2021.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.